Mark Murcko, Ph.D.
DirectoratRelay Therapeutics· In proxies 2023–2025
Mark Murcko, Ph.D. sits on 6 public boards.
Boards1
- Relay TherapeuticsDirector · 7 yr on the boardIndependentResearch and Development (Chair)—Paid as an executive
'%20fill='%23FEFEFE'%3e%3cpath%20d='M67.7444739,25%20L33.1043073,38.2478027%20L34.7958615,41.1131448%20L41.0490807,51.7151219%20L29.0986607,51.7151219%20L28,54.6065381%20L57.1428867,79%20L60.0675871,77.3612019%20L46.8800441,55.0029363%20L63.0277166,55.0032886%20L63.8216155,51.7151219%20L70,26.9178624%20L67.7444739,25%20Z%20M38,39.9222264%20L66,29%20L60.3908123,52%20L44.9725093,52%20L38,39.9222264%20Z%20M34,55%20L43.1090246,55%20L52,70%20L34,55%20Z'%20id='Fill-1-Copy'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Relay TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +37%
- BioHybrid Solutions Holdings, LLCPublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- HiBio Therapeutics, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Octant, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Octant, Inc. andPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- RADD Therapeutics, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?